Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson’s disease: a systematic review protocol
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2046-4053
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson’s disease: a systematic review protocol ; volume:10 ; number:1 ; day:25 ; month:6 ; year:2021 ; pages:1-6 ; date:12.2021
Systematic Reviews ; 10, Heft 1 (25.6.2021), 1-6, 12.2021
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13643-021-01736-z
- URN
-
urn:nbn:de:101:1-2021101001440831058550
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek.
Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Karimi, Aliasghar
- Elmi, Mitra
- Shiri, Zahra
- Baharvand, Hossein
- SpringerLink (Online service)
Ähnliche Objekte (12)
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Pluripotent Stem Cell-derived Dopaminergic Neurons for Studying Developmental Neurotoxicity
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
Patient-Specific Induced Pluripotent Stem Cell Models of Parkinson’s Disease
Cell therapy for Parkinson’s disease with induced pluripotent stem cells
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Modulation of human induced neural stem cell-derived dopaminergic neurons by DREADD reveals therapeutic effects on a mouse model of Parkinson’s disease
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Characterisation of human induced pluripotent stem cell-derived hepatocyte-like cells and endodermal progenitors
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Pluripotent Stem Cell-derived Dopaminergic Neurons for Studying Developmental Neurotoxicity
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
Patient-Specific Induced Pluripotent Stem Cell Models of Parkinson’s Disease
Cell therapy for Parkinson’s disease with induced pluripotent stem cells
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Modulation of human induced neural stem cell-derived dopaminergic neurons by DREADD reveals therapeutic effects on a mouse model of Parkinson’s disease
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Characterisation of human induced pluripotent stem cell-derived hepatocyte-like cells and endodermal progenitors
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Pluripotent Stem Cell-derived Dopaminergic Neurons for Studying Developmental Neurotoxicity
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
Patient-Specific Induced Pluripotent Stem Cell Models of Parkinson’s Disease
Cell therapy for Parkinson’s disease with induced pluripotent stem cells
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Modulation of human induced neural stem cell-derived dopaminergic neurons by DREADD reveals therapeutic effects on a mouse model of Parkinson’s disease
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease